In search of new strategies against life-threatening tuberculosis infections, a team from the Technical University of Munich (TUM), as well as Harvard University and Texas A&M University in the USA have found a new ally. They discovered a substance that interferes with the mycomembrane formation of the bacterium. It is effective even in low concentrations and when combined with known antibiotics their effectiveness is improved by up to 100-fold.
Among the greatest challenges when treating life-threatening tuberculosis infections is the increasing resistance to antibiotics. But the pathogen itself also makes the life of doctors difficult: its dense mycomembrane hampers the effect of many medications. A team of scientists headed by Stephan A. Sieber, Professor of Organic Chemistry at TU Munich, has discovered a substance that perturbs the formation of this membrane significantly.
The mycomembrane of the tuberculosis pathogen Mycobacterium tuberculosis consists of a lipid double layer that encapsulates the cell wall, forming an exterior barrier. Structural hallmarks are mycolic acids, branched beta-hydroxy fatty acids with two long hydrocarbon chains. The team hypothesizes that similarly structured beta lactones could “mask” themselves as mycolic acid to enter the mycolic acid metabolic pathways and then block the decisive enzymes.
In the context of an extensive search, the interdisciplinary team of scientists hit the bullseye with the beta lactone EZ120. It does indeed inhibit the biosynthesis of the mycomembrane and kills mycobacteria effectively. Using enzyme assays and mass spectroscopy investigations, Dr. Johannes Lehmann, a researcher at the Chair of Organic Chemistry II at TU Munich, demonstrated during his doctoral work that the new inhibitor blocks especially the enzymes Pks13 and Ag85, which play a key role in the development of mycomembranes.
EZ120 is effective even in low doses, easily passes the mycomembrane and exhibits only low toxicity to human cells. The combined application of this substance with known antibiotics showed a synergistic effect leading to significantly increased effectiveness.”Vancomycin, a common antibiotic, and EZ120 work together very well,” says Prof. Sieber, who heads the Chair of Organic Chemistry II. “When used together, the dose can be reduced over 100-fold.
“The scientists suspect that disrupting the mycomembrane enables antibiotics to enter the bacteria more easily. This is a new mode of action and might be a starting point for novel tuberculosis therapies.
Learn more: Double strike against tuberculosis
The Latest on: Tuberculosis
- Case of Tuberculosis confirmed in Broome County on November 9, 2018 at 1:40 pm
(WBNG) — The Broome County Health Department says an active case of Tuberculosis has been confirmed in the area and is not an on-going threat to the public. Broome County Health Department ... […]
- Cleveland Clinic employee being tested for tuberculosis on November 9, 2018 at 11:02 am
CLEVELAND, Ohio – A Cleveland Clinic employee who works in pediatrics is on leave while being tested for a potential case of tuberculosis, according to a Clinic statement. The Clinic said there is a “ ... […]
- Cleveland Clinic employee tested for possible case of tuberculosis on November 9, 2018 at 10:44 am
CLEVELAND- The Cleveland Clinic is currently testing an employee for a possible case of tuberculosis, according to a news release by the hospital Friday. The employee works for the main campus ... […]
- Potential Tuberculosis Exposure At Lucky Lady Casino In San Diego on November 6, 2018 at 2:47 pm
SAN DIEGO, CA – People who visited the Lucky Lady Casino in San Diego on weekends over a six-month period ending in late September may have been exposed to tuberculosis, county health officials ... […]
- Movement, evolutionary history of tuberculosis in China on November 5, 2018 at 9:26 pm
A genetic scan of a massive number of samples taken from tuberculosis patients across China has shown a surprising genetic uniformity: just two 'strains' of the tuberculosis bacterium account for 99.4 ... […]
- Study shows movement, evolutionary history of tuberculosis in China on November 5, 2018 at 8:19 am
Map shows movement of two subtypes of the tuberculosis bacterium lineage 4 after `it was introduced, presumably by infected sailors. Today, lineage 4 causes 17 percent of China's tuberculosis cases. […]
- Pulmonary tuberculosis can be cured with shorter treatment, study finds on November 5, 2018 at 8:03 am
Almost half of the nearly 10 million patients with active tuberculosis each year could potentially be cured with significantly shorter treatments than current guidelines recommend, a new analysis ... […]
- Public Health Department confirms tuberculosis case at Taylor school on November 2, 2018 at 4:00 pm
TAYLOR, Mich. - Wayne County Department of Health, Veterans and Community Wellness confirmed there was one case of tuberculosis at Randall Elementary School in Taylor. The child has been isolated and ... […]
- Lymph nodes are niches for prolonged tuberculosis infection on November 1, 2018 at 11:06 am
Lymph nodes can contain large numbers of tuberculosis-causing bacteria and serve as long-term reservoirs of bacterial persistence, according to a study published November 1 in the open-access journal ... […]
- Tuberculosis vaccine: wonder drug for diabetes and more? on October 31, 2018 at 1:54 pm
Tuberculosis is the world's leading infectious cause of death. BCG is a vaccine given to infants and children in countries where TB is common. Now, recent reports are revealing it's helping more than ... […]
via Google News and Bing News